Intriguingly, glutamate or amyloid peptides interfere with IGF1R signaling, leading to a state of IGF1 resistance in Alzheimer’s disease, a trait that may profoundly affect its course84. Here, IGF1R is linked to early-onset autosomal dominant Alzheimer disease.